Ticker	Volume	Price	Price Delta
DJIA	15,294.50	-12.67	-0.08%
S&P 500	1,650.51	-4.84	-0.29%
Nasdaq	3,459.42	-3.88	-0.11%

Ticker

Volume

Price

Price Delta

DJIA

15,294.50

-12.67

-0.08%

S&P 500

1,650.51

-4.84

-0.29%

Nasdaq

3,459.42

-3.88

-0.11%

Ticker	Volume	Price	Price Delta
STOXX 50	2,770.64	-6.14	-0.22%
FTSE 100	6,656.47	-40.32	-0.60%
DAX	8,293.90	-58.08	-0.70%

Ticker

Volume

Price

Price Delta

STOXX 50

2,770.64

-6.14

-0.22%

FTSE 100

6,656.47

-40.32

-0.60%

DAX

8,293.90

-58.08

-0.70%

Ticker	Volume	Price	Price Delta
Nikkei	14,612.50	+128.47	0.89%
Hang Seng	22,618.70	-51.01	-0.23%
S&P/ASX 200	4,983.50	-78.95	-1.56%

Ticker

Volume

Price

Price Delta

Nikkei

14,612.50

+128.47

0.89%

Hang Seng

22,618.70

-51.01

-0.23%

S&P/ASX 200

4,983.50

-78.95

-1.56%

Exchange: NASDAQ GM
Sector: Consumer, Non-cyclical
Industry: Pharmaceuticals
Sub-Industry: Medical-Drugs

Regulus Therapeutics Inc

+ Add to Watchlist

RGLS:US

7.3400 USD 0.2000 2.80%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 20:10:00 ET on 05/23/2013.

News for Regulus Therapeutics Inc (RGLS)

COMPANY NEWS
PRESS RELEASES
INDUSTRY NEWS

AstraZeneca CEO Chases Multiple Strands in RNA Drug Quest

Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference Published May 21, 2013
Alnylam to Webcast Presentation at Deutsche Bank 38th Annual dbAccess Health Care Conference Published May 21, 2013
Alnylam Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 Published May 17, 2013
Alnylam to Webcast Presentation at 2013 UBS Global Healthcare Conference Published May 15, 2013
Regulus Provides Update on 'Road to the Clinic' Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights Published May 14, 2013
Alnylam to Webcast Presentation at 2013 Bank of America Merrill Lynch Health Care Conference Published May 08, 2013
Isis Reports Financial Results and Highlights for First Quarter 2013 Published May 07, 2013
Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call Published May 07, 2013
Alnylam Pharmaceuticals Reports First Quarter 2013 Financial Results Published May 06, 2013
Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer Published May 06, 2013
Webcast Alert: Isis Pharmaceuticals' First Quarter 2013 Financial Results Conference Call Published May 02, 2013
Alnylam to Webcast Conference Call Discussing First Quarter 2013 Financial Results Published Apr 29, 2013
Regulus to Present at 12th Annual Needham Healthcare Conference Published Apr 24, 2013
Alnylam to Webcast Presentation at 12th Annual Needham Healthcare Conference Published Apr 23, 2013

« Previous 1 2 3 4 5 Next »

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Regulus Therapeutics Inc

RGLS:US

Share this quote:

News for Regulus Therapeutics Inc (RGLS)

COMPANY NEWS

PRESS RELEASES

INDUSTRY NEWS

Bloomberg.com

About

Support and Contact

Stay Connected

Bloomberg Terminal

Bloomberg Premium Services

Mobile Apps

Regulus Therapeutics Inc

RGLS:US

Share this quote:

News for Regulus Therapeutics Inc (RGLS)

COMPANY NEWS

PRESS RELEASES

INDUSTRY NEWS

Bloomberg.com

About

Support and Contact

Stay Connected

Bloomberg Terminal

Related Bloomberg Sites

Bloomberg Premium Services

Mobile Apps